Eton Pharmaceuticals (ETON) Retained Earnings (2017 - 2026)
Eton Pharmaceuticals (ETON) posted Retained Earnings of -$112.5 million for Q4 2025, down 182.07% sequentially from $137.1 million in Q3 2025, and down 4.26% YoY from -$117.5 million in Q4 2024.
Eton Pharmaceuticals (ETON) Retained Earnings (2017 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Retained Earnings for 9 years, with the latest figure at -$112.5 million in Q4 2025.
- Quarterly Retained Earnings fell 4.26% year-over-year to -$112.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$112.5 million (down 4.26% YoY) and the FY2025 annual result came in at -$112.5 million, down 4.26% from the prior year.
- Retained Earnings eased to -$112.5 million in Q4 2025 per ETON's latest filing, from $137.1 million in the prior quarter.
- Over five years, Retained Earnings peaked at $137.1 million in Q3 2025 and troughed at -$112.5 million in Q4 2025.
- A 5-year average of -$90.5 million and a median of -$103.6 million in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2025: Retained Earnings dropped 18.85% in 2021, then surged 227.76% in 2025.
- Over 5 years, Retained Earnings stood at -$94.1 million in 2021, then slipped by 9.59% to -$103.1 million in 2022, then retreated by 0.91% to -$104.1 million in 2023, then dropped by 3.67% to -$107.9 million in 2024, then fell by 4.26% to -$112.5 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$112.5 million, $137.1 million, and -$112.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | 3.75 Bn |
| 10 | Eton Pharmaceuticals | 1.67 Bn | 1.64 Bn | 25.41 Mn | -99.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99.36 Mn |
| Dec 31, 2025 | -112.49 Mn |
| Sep 30, 2025 | 137.08 Mn |
| Jun 30, 2025 | -112.05 Mn |
| Mar 31, 2025 | -109.47 Mn |
| Dec 31, 2024 | -107.89 Mn |
| Sep 30, 2024 | -107.30 Mn |
| Jun 30, 2024 | -107.92 Mn |
| Mar 31, 2024 | -104.88 Mn |
| Dec 31, 2023 | -104.07 Mn |
| Sep 30, 2023 | -101.81 Mn |
| Jun 30, 2023 | -101.24 Mn |
| Mar 31, 2023 | -105.79 Mn |
| Dec 31, 2022 | -103.13 Mn |
| Sep 30, 2022 | -104.05 Mn |
| Jun 30, 2022 | -101.00 Mn |
| Mar 31, 2022 | -99.44 Mn |
| Dec 31, 2021 | -94.11 Mn |
| Sep 30, 2021 | -95.15 Mn |
| Jun 30, 2021 | -89.06 Mn |